BioFlag Launches Revolutionary Probiotic Solutions at Vitafoods Europe 2025
BioFlag Launches Revolutionary Probiotic Solutions at Vitafoods Europe 2025
Barcelona, Spain – May 20, 2025 – BioFlag Co., Ltd., a prominent player in the probiotics industry hailing from China, made a significant impact at the recently held Vitafoods Europe 2025. The company showcased its line of scientifically validated functional probiotics, drawing considerable attention from the global media and health enthusiasts alike.
At this prestigious event, BioFlag emphasized its commitment to advancing gut health through innovative approaches. The company highlighted several clinically-proven probiotic strains, each with its specific health benefits. Their product lineup includes solutions targeting various aspects of wellbeing: gut health, immune regulation, metabolic health, weight management, oral care, and emotional wellness. With strict adherence to both European and American standards, BioFlag also introduced customized probiotics tailored to meet specific health needs.
Among the star products presented were:
1. Bifidobacterium animalis subsp. lactis BL-99 - This strain is sourced from BioFlag's unique maternal-infant probiotic strain library and holds an impressive 12 Chinese invention patents. It supports gut health, immune regulation, and even bone health. BL-99 is widely utilized in infant formulas, yogurts, and dietary supplements, highlighting its versatility and safety.
2. Lactobacillus paracasei K56 - Isolated from the gut of healthy Chinese infants, this strain has demonstrated clinically-proven results in reducing body fat, visceral fat, and waist circumference. With 9 patents and 12 research studies backing its efficacy, K56 has emerged as a game-changer in body composition management.
3. Bifidobacterium animalis subsp. lactis CP-9 - Derived from the breast milk of healthy Chinese mothers, CP-9 is patented in China for its anti-obesity effects and its potential in the treatment or prevention of jaundice.
BioFlag's expansive capabilities in the probiotics sector were underscored by its comprehensive industrial chain, boasting:
- - A proprietary library comprising over 3,500 strains and more than 30 functional screening platforms.
- - Over 130 patents in its portfolio alongside 100+ published scientific papers, establishing it as a leader in probiotic research and development.
- - International certifications including GMP, FSSC22000 and HALAL, ensuring high standards in production and safety.
- - A robust production capacity that encompasses powders, tablets, capsules, and assorted dosage forms.
Throughout the exhibition, BioFlag engaged in numerous cooperative discussions with enterprises and institutions from Europe, North America, and other regions, signaling its intent to expand its international partnerships. A company representative remarked, “Drawing on nearly two decades of expertise in functional probiotics, we remain steadfast in our commitment to innovate in research and development, as well as intelligent manufacturing, to provide superior health solutions to our global clientele.”
For those interested in exploring more about BioFlag and their innovative probiotic offerings, additional information is available on their official website: BioFlag.
As BioFlag continues to pioneer advancements in probiotics, its active presence in exhibitions like Vitafoods Europe serves as a testament to its dedication to enhancing global health through science-backed solutions.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.